Oncolytic Viruses: An Inventory of Shedding Data from Clinical Trials and Elements for the Environmental Risk Assessment
Attenuated and/or genetically modified oncolytic viruses (OV) gain increasing interest as a promising approach for cancer therapy. Beside the assessment of subject safety, quality and efficacy aspects of medicinal products for human use, genetically modified viruses are also governed by EU regulator...
Main Authors: | Sheela Onnockx, Aline Baldo, Katia Pauwels |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-09-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/11/9/1448 |
Similar Items
-
Clinical Application of Oncolytic Viruses: A Systematic Review
by: Mary Cook, et al.
Published: (2020-10-01) -
Recent advances of oncolytic virus in cancer therapy
by: Moumita Mondal, et al.
Published: (2020-10-01) -
The Evolution and Future of Targeted Cancer Therapy: From Nanoparticles, Oncolytic Viruses, and Oncolytic Bacteria to the Treatment of Solid Tumors
by: Kyle M. Pierce, et al.
Published: (2021-11-01) -
Oncolytic Virus Engineering and Utilizations: Cancer Immunotherapy Perspective
by: Palaniyandi Muthukutty, et al.
Published: (2023-07-01) -
Recent advances in oncolytic virus therapy for hepatocellular carcinoma
by: Licheng Zhu, et al.
Published: (2023-04-01)